Antibiotic resistance is a phenomenon that occurs when bacteria no longer respond to antibiotics making these treatments ineffective; this is a pivotal problem in human health, causing 4.95 million deaths worldwide in 2019 with a predicted growth to 10 million deaths by 2050. A biofilm is a community of microorganisms held together by a self-produced extracellular matrix. Bacteria making up biofilms show an increased drug tolerance when compared to their planktonic state. The ability of biofilm to survive when high concentrations of antibiotics are present is called recalcitrance. It is crucial to examine the existing correlation between antibiotic resistance and biofilm, analysing whether the biofilm milieu inclines bacteria to the evolution of antibiotic resistance characteristics other than the one naturally occurring in the biofilm structure. This work focuses on understanding this phenomenon, to highlight some guidelines and starting points in the research for Synthetic Biology-based therapeutical strategies and approaches, driving the design of engineered biological systems capable of exerting biofilm dispersion through engineered bacteriophages by carrying out extracellular polymeric substances synthesis inhibition and degradation, as well as acting on quorum sensing interruption.

Antibiotic resistance is a phenomenon that occurs when bacteria no longer respond to antibiotics making these treatments ineffective; this is a pivotal problem in human health, causing 4.95 million deaths worldwide in 2019 with a predicted growth to 10 million deaths by 2050. A biofilm is a community of microorganisms held together by a self-produced extracellular matrix. Bacteria making up biofilms show an increased drug tolerance when compared to their planktonic state. The ability of biofilm to survive when high concentrations of antibiotics are present is called recalcitrance. It is crucial to examine the existing correlation between antibiotic resistance and biofilm, analysing whether the biofilm milieu inclines bacteria to the evolution of antibiotic resistance characteristics other than the one naturally occurring in the biofilm structure. This work focuses on understanding this phenomenon, to highlight some guidelines and starting points in the research for Synthetic Biology-based therapeutical strategies and approaches, driving the design of engineered biological systems capable of exerting biofilm dispersion through engineered bacteriophages by carrying out extracellular polymeric substances synthesis inhibition and degradation, as well as acting on quorum sensing interruption.

Correlation between biofilm and antibiotic resistance and possible therapeutic approaches

D'ANGELO, GIORGIA
2022/2023

Abstract

Antibiotic resistance is a phenomenon that occurs when bacteria no longer respond to antibiotics making these treatments ineffective; this is a pivotal problem in human health, causing 4.95 million deaths worldwide in 2019 with a predicted growth to 10 million deaths by 2050. A biofilm is a community of microorganisms held together by a self-produced extracellular matrix. Bacteria making up biofilms show an increased drug tolerance when compared to their planktonic state. The ability of biofilm to survive when high concentrations of antibiotics are present is called recalcitrance. It is crucial to examine the existing correlation between antibiotic resistance and biofilm, analysing whether the biofilm milieu inclines bacteria to the evolution of antibiotic resistance characteristics other than the one naturally occurring in the biofilm structure. This work focuses on understanding this phenomenon, to highlight some guidelines and starting points in the research for Synthetic Biology-based therapeutical strategies and approaches, driving the design of engineered biological systems capable of exerting biofilm dispersion through engineered bacteriophages by carrying out extracellular polymeric substances synthesis inhibition and degradation, as well as acting on quorum sensing interruption.
2022
Correlation between biofilm and antibiotic resistance and possible therapeutic approaches
Antibiotic resistance is a phenomenon that occurs when bacteria no longer respond to antibiotics making these treatments ineffective; this is a pivotal problem in human health, causing 4.95 million deaths worldwide in 2019 with a predicted growth to 10 million deaths by 2050. A biofilm is a community of microorganisms held together by a self-produced extracellular matrix. Bacteria making up biofilms show an increased drug tolerance when compared to their planktonic state. The ability of biofilm to survive when high concentrations of antibiotics are present is called recalcitrance. It is crucial to examine the existing correlation between antibiotic resistance and biofilm, analysing whether the biofilm milieu inclines bacteria to the evolution of antibiotic resistance characteristics other than the one naturally occurring in the biofilm structure. This work focuses on understanding this phenomenon, to highlight some guidelines and starting points in the research for Synthetic Biology-based therapeutical strategies and approaches, driving the design of engineered biological systems capable of exerting biofilm dispersion through engineered bacteriophages by carrying out extracellular polymeric substances synthesis inhibition and degradation, as well as acting on quorum sensing interruption.
Biofilm
AMR
Therapy
File in questo prodotto:
File Dimensione Formato  
D'Angelo_Giorgia.pdf

accesso aperto

Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF Visualizza/Apri

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/60342